drugset / Trial / NCT02366364
Study of Safety, Tolerability and Pharmacokinetics of NRX-1074 in Normal Healthy Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the safety and tolerability of multiple oral (PO) ascending doses of NRX-1074 in normal healthy volunteers.
Timeline
- Start
- 2015-02
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apimostinel | Protein / enzyme biologic | 375 mg | Oral |
| Subject | Apimostinel | Protein / enzyme biologic | 500 mg | Oral |
| Subject | Apimostinel | Protein / enzyme biologic | 750 mg | Oral |